Steiner, Israel <br/><br/>
PML: underdiagnosed in MS patients on natalizumab.  [electronic resource] 

 -  The Lancet. Neurology  Jun 2010 
 - 564; author reply 564-5 p.  digital 
<br/><br/> Publication Type: Comment; Letter 
<br/><br/><label>ISSN: </label>1474-4465 
<br/><br/><label>Standard No.: </label>10.1016/S1474-4422(10)70122-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Disease Progression<br/>Early Diagnosis<br/>Europe--epidemiology<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Incidence<br/>Leukoencephalopathy, Progressive Multifocal--diagnosis<br/>Multiple Sclerosis--diagnosis<br/>Natalizumab<br/>Review Literature as Topic<br/>United States--epidemiology